The preliminary results of the clinical trial involving AstraZeneca's AZD0466 and the drug delivery platform developed by Australian company Starpharma (ASX:SPL) have been presented at the 2022 American Society of Hematology annual meeting.
Positive preliminary results from trial involving candidate from AZ-Starpharma collaboration
December 13, 2022 Australian Biotech
Latest Video
New Stories
-
The 'Week in Review' - 27 January
January 27, 2023 - - Podcast -
Forget about experts and terms of reference until we get a transparent process
January 27, 2023 - - Latest News -
Australia Day recognition for senior officials and pharmacy leaders
January 27, 2023 - - Latest News -
Is this a change of heart from the former health department secretary?
January 27, 2023 - - Latest News -
New chair for Australian genomics industry organisation
January 26, 2023 - - Australian Biotech -
MEDLAB receives Import Certificate from UK Home Office for NanaBis
January 26, 2023 - - Australian Biotech -
Alterity Therapeutics launches ATH434 Phase 2 clinical trial in Italy
January 26, 2023 - - Australian Biotech